Thus, the treatment with rhCCL3 upregulated the expressions of MMP-2 and VEGF-A in multiple ESCC cell lines via PI3K/Akt and MEK/ERK pathways. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.